What laboratory tests are used for the diagnosis of Small Intestinal Bacterial Overgrowth (SIBO)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The gold standard test for diagnosing Small Intestinal Bacterial Overgrowth (SIBO) is jejunal aspirate with quantitative culture for aerobic and anaerobic organisms, but due to its invasive nature, glucose or lactose hydrogen breath tests are more commonly used. When considering diagnostic tests for SIBO, it's essential to weigh the pros and cons of each option. The hydrogen/methane breath test is a popular choice, as it measures gas production after ingesting a carbohydrate substrate like lactulose or glucose 1. Patients fast for 12 hours before the test and provide baseline breath samples, then consume the test substrate and provide breath samples at regular intervals over 2-3 hours. Elevated hydrogen (>20 ppm) or methane (>10 ppm) levels above baseline, or an early rise in hydrogen, suggest SIBO. Some key points to consider when diagnosing SIBO include:

  • The importance of measuring methane as well as hydrogen to increase sensitivity, despite the lack of standardization and poor sensitivity and specificity for these tests 1
  • The role of empirical treatment with broad-spectrum antibiotics such as rifaximin if the diagnosis is likely, with recurrent courses of treatment potentially required 1
  • The potential for other causes of recurrent symptoms, such as bile acid malabsorption, to be considered and investigated using tests like SeHCAT study or serum 7α-hydroxy-4-cholesten-3-one 1 In clinical practice, the diagnosis of SIBO is often based on a combination of clinical symptoms, medical history, and diagnostic test results. The hydrogen/methane breath test is a useful diagnostic tool, but it should be interpreted in the context of the patient's overall clinical presentation. It's also important to note that some guidelines suggest that there is no role for testing for SIBO in patients with typical IBS symptoms 1. However, in patients with symptoms suggestive of SIBO, such as bloating, diarrhea, and abdominal pain, further investigation and treatment may be necessary. In terms of treatment, antibiotics like rifaximin or herbal antimicrobials may be effective in managing SIBO symptoms 1. Overall, a comprehensive approach to diagnosing and treating SIBO is essential to improve patient outcomes and quality of life.

From the Research

Diagnosis of Small Intestinal Bacterial Overgrowth (SIBO)

  • SIBO is characterized by an excessive amount of bacteria in the small intestine, leading to symptoms such as bloating, pain, gas, and diarrhea 2.
  • Several tests have been proposed for the diagnosis of SIBO, including:
    • Glucose breath test 3, 2, 4, 5
    • Lactulose breath test 2, 5, 6
    • Small intestinal aspiration and culture 2, 5
  • However, there is a lack of standardization of these tests and their interpretation, making diagnosis challenging 2.

Laboratory Tests for SIBO

  • Glucose breath test is a non-invasive test that measures the amount of hydrogen and/or methane in the breath after ingesting glucose 3, 4, 5.
  • Lactulose breath test is also a non-invasive test that measures the amount of hydrogen in the breath after ingesting lactulose 6.
  • Small intestinal aspiration and culture is an invasive test that involves collecting a sample of fluid from the small intestine to culture for bacteria 2, 5.

Limitations of Current Evidence

  • There is a lack of consensus and clarity regarding the natural history and methods for diagnosing SIBO 2.
  • The current evidence for the diagnosis and treatment of SIBO is limited, and more research is needed to develop a systematic approach for the management of SIBO 2, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Preferential usage of rifaximin for the treatment of hydrogen-positive smallintestinal bacterial overgrowth.

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru, 2019

Research

Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole.

European review for medical and pharmacological sciences, 2009

Research

Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management.

Clinical and translational gastroenterology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.